 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only...

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Virax Biolabs names Dr. Nigel McCracken as COO

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth...

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Virax Biolabs Group Limited (NASDAQ:VRAX Get Free Report) saw a significant decrease in short interest in August. As of August 15th, there was short interest totalling 4,900 shares, a decrease of 80.3% from the July 31st total of 24,900 shares. Currently, 0.1% of the shares of the stock are sold ...

Virax Biolabs Group Limited (NASDAQ:VRAX) Sees Significant Drop in Short Interest

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid PR Newswire LONDON, Aug. 3, 2023 LONDON, Aug. 3, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ('Virax' or the...

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities PR Newswire LONDON and DUBAI, UAE, July 18, 2023 LONDON andDUBAI, UAE, July 18, 2023...

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

Virax Biolabs Group Limited (NASDAQ:VRAX Free Report) was the target of a significant increase in short interest in June. As of June 15th, there was short interest totalling 286,700 shares, an increase of 42.2% from the May 31st total of 201,600 shares. Based on an average trading volume of 592,100 ...

Short Interest in Virax Biolabs Group Limited (NASDAQ:VRAX) Grows By 42.2%

Virax Biolabs' CEO James Foster Issues Letter to Shareholders Virax Biolabs' CEO James Foster Issues Letter to Shareholders PR Newswire LONDON and DUBAI, UAE, June 14, 2023 LONDON andDUBAI, UAE, June 14, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ('Virax' or the 'Company&quot...

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Virax Biolabs Group (NASDAQ:VRAX Get Rating) and Aspira Womens Health (NASDAQ:AWH Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, ...

Virax Biolabs Group (NASDAQ:VRAX) & Aspira Women's Health (NASDAQ:AWH) Head-To-Head Analysis

Virax Biolabs Group (NASDAQ:VRAX  Get Rating) and Achieve Life Sciences (NASDAQ:ACHV  Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, ...

Head-To-Head Comparison: Virax Biolabs Group (NASDAQ:VRAX) & Achieve Life Sciences (NASDAQ:ACHV)

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

Watchers	3,361
52-Wk Low	$0.302
52-Wk High	$3.20

Market Cap	$4.82M
Volume (M)	79,683.00
52-Wk High	$3.20
52-Wk Low	$0.302

Current Price	$0.31
Prev Close	$0.3102
Open	$0.3102
Dividend Yield	0.00%
50-Day Moving Average	$0.371
Beta	0.00
Avg. Volume	95,662.22
PE Ratio	-0.81

52-Week High	$3.20
52-Week Low	$0.302
Market Capitalization	$4.82M
EPS	-$0.382
Price to Book	0.53
Revenue Per Employee	$778.27
Enterprise Value/EBITDA	-0.24

VRAX VIRAX BIOLABS GROUP LIMITED

About

Feed

News

Fundamentals